MedTrace Logo

Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions

NCT02527954 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2019-03-08

No results posted yet for this study

Summary

In this study, investigators assess, using Fluorescence in situ Hybridization (FISH) and Comparative Genomic Hybridization (CGH) arrays for Preimplantation Genetic Screening (PGS), the incidence of aneuploidies in spermatozoa and embryos from infertile men with and without microdeletions who undergo assisted reproduction in their clinics.

Conditions

  • Male Sterility Due to Y-chromosome Deletions

Sponsors & Collaborators

  • IVI Murcia

    collaborator OTHER

  • Igenomix

    collaborator INDUSTRY

  • Instituto Valenciano de Infertilidad, IVI Alicante

    lead OTHER

Principal Investigators

  • Purificación Hernández-Vargas, PhD · Instituto Valenciano de Infertilidad, IVI Alicante

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-22
Primary Completion
2018-06-11
Completion
2018-06-11

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02527954 on ClinicalTrials.gov